EUVIMEDEUVIMED entdecken
Crossref

Pulmonary vein isolation or atrioventricular junction ablation – what for whom?

Aleksander Bardyszewski, Paweł Derejko, Jacek Kuśnierz

In a Good Rhythm · 2017

DOI: 10.5604/01.3001.0010.7489 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In a Good Rhythm, 2017. Verfasst von Aleksander Bardyszewski und 2 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atrial fibrillation is the most common reason for arrhythmic hospitalizations and one of the leading causes ofstroke. Recently we have been witnessing growing morbidity related to this arrhythmia, mostly in developedcountries. The therapeutic approach should incorporate both elimination and limitation of risk factors and tailoredpharmacologic and invasive treatment. There are two possible strategies for invasive management ofsymptomatic atrial fibrillation: rhythm control and heart rate control. The first strategy implies pulmonaryvein isolation (PVI) and it should be restricted to younger patients with fewer risk factors. The second strategy,which involves pacer implantation and atrioventricular junction ablation, may be considered in older patientswith numerous risk factors and comorbidities.

Zitieren

APA

Bardyszewski, A., Derejko, P., & Kuśnierz, J. (2017). Pulmonary vein isolation or atrioventricular junction ablation – what for whom?. In a Good Rhythm. https://doi.org/10.5604/01.3001.0010.7489

Vancouver

Bardyszewski A, Derejko P, Kuśnierz J. Pulmonary vein isolation or atrioventricular junction ablation – what for whom?. In a Good Rhythm. 2017. doi:10.5604/01.3001.0010.7489

BibTeX
@article{Bardyszewski2017,
  author = {Bardyszewski, Aleksander and Derejko, Paweł and Kuśnierz, Jacek},
  title = {Pulmonary vein isolation or atrioventricular junction ablation – what for whom?},
  journal = {In a Good Rhythm},
  year = {2017},
  doi = {10.5604/01.3001.0010.7489}
}
Kostenlos starten →